Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...
For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which is ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
Zydus Lifesciences Limited has launched Semaglutide Injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME ...
Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India: Our Bureau, Mumbai Saturday, March 21, 2026, 14:15 Hrs [IST] Sun Pharmaceut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results